BE802981A - Sel enzymatique, son procede de preparation et compositions therapeutiques le renfermant - Google Patents

Sel enzymatique, son procede de preparation et compositions therapeutiques le renfermant

Info

Publication number
BE802981A
BE802981A BE134028A BE134028A BE802981A BE 802981 A BE802981 A BE 802981A BE 134028 A BE134028 A BE 134028A BE 134028 A BE134028 A BE 134028A BE 802981 A BE802981 A BE 802981A
Authority
BE
Belgium
Prior art keywords
enzymatic
salt
preparation process
compositions containing
therapeutic compositions
Prior art date
Application number
BE134028A
Other languages
English (en)
Original Assignee
Errekappa Euroterapici Sas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Errekappa Euroterapici Sas filed Critical Errekappa Euroterapici Sas
Publication of BE802981A publication Critical patent/BE802981A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • C12P19/28—N-glycosides
    • C12P19/38—Nucleosides
    • C12P19/40—Nucleosides having a condensed ring system containing a six-membered ring having two nitrogen atoms in the same ring, e.g. purine nucleosides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Microbiology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • General Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Neurosurgery (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
BE134028A 1972-08-02 1973-07-30 Sel enzymatique, son procede de preparation et compositions therapeutiques le renfermant BE802981A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2779372 1972-08-02

Publications (1)

Publication Number Publication Date
BE802981A true BE802981A (fr) 1973-11-16

Family

ID=11222342

Family Applications (1)

Application Number Title Priority Date Filing Date
BE134028A BE802981A (fr) 1972-08-02 1973-07-30 Sel enzymatique, son procede de preparation et compositions therapeutiques le renfermant

Country Status (29)

Country Link
US (1) US3893999A (fr)
JP (1) JPS5235726B2 (fr)
AR (1) AR195350A1 (fr)
AT (1) AT341684B (fr)
AU (1) AU474015B2 (fr)
BE (1) BE802981A (fr)
CA (1) CA1006872A (fr)
CH (1) CH592112A5 (fr)
CS (1) CS195254B2 (fr)
DD (1) DD107461A5 (fr)
DE (1) DE2336401C3 (fr)
DK (1) DK131868C (fr)
ES (1) ES417377A1 (fr)
FI (1) FI52466C (fr)
FR (1) FR2194425B1 (fr)
GB (1) GB1425384A (fr)
HK (1) HK31580A (fr)
HU (1) HU167266B (fr)
IE (1) IE37913B1 (fr)
IL (1) IL42764A (fr)
MX (1) MX4544E (fr)
NL (1) NL152864B (fr)
NO (1) NO137941C (fr)
PL (1) PL87381B1 (fr)
RO (1) RO63451A (fr)
SE (1) SE400085B (fr)
SU (1) SU646915A3 (fr)
YU (1) YU36037B (fr)
ZA (1) ZA734876B (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS51125717A (en) * 1974-07-12 1976-11-02 Bioresearch Sas Preparation of ssadenosylmethionine sulfonate

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE39517B1 (en) * 1973-06-27 1978-10-25 Bioresearch Sas Double salts of s-adenosyl-l-methhionine
US4109079A (en) * 1975-10-16 1978-08-22 Yamasa Shoyu Kabushiki Kaisha Stabilized s-adenosyl-l-methionine preparations
GB2064523B (en) * 1979-12-04 1983-06-29 Kanegafuchi Chemical Ind Stable composition of s-adenosyl-l-methionine
IT1137640B (it) 1981-08-24 1986-09-10 Bioresearch Srl Sali stabili della s-adenosilmetionina,processo per la loro preparazione e composizioni terapeutiche che li comprendono come principio attivo
IT1137892B (it) * 1981-08-24 1986-09-10 Bioresearch Srl Sali stabili della s-adenosilmetionina,processo per la loro preparazione e composizioni terapeutiche che li comprendono come principio attivo
IT1139974B (it) * 1981-09-11 1986-09-24 Bioresearch Srl Derivati della s-adenosilmetionina,processo per la preparazione e composizioni terapeutiche che li contengono come principio attivo
IT1169773B (it) * 1983-08-24 1987-06-03 Bioresearch Spa Processo per la produzione di sali stabili della solfo-adenosil-l-metionina
IT1169774B (it) * 1983-08-24 1987-06-03 Bioresearch Spa Composizioni terapeutiche iniettabili contenenti sali stabili della s-adenosil-l-metionina
IT1173992B (it) * 1984-05-16 1987-06-24 Bioresearch Spa Sali stabili della solfo-adenosil-l-metionina (same) particolarmente idonei per uso farmaceutico orale
IT1173990B (it) * 1984-05-16 1987-06-24 Bioresearch Spa Sali stabili della solfo-adenosil-l-metionina (same) particolarmente adatti per uso parenterale
IT1200589B (it) * 1985-02-14 1989-01-27 Gibipharma Spa Derivati naturali attivita farmagologica
AU2538588A (en) * 1987-10-09 1989-05-02 Mario De Rosa Lipophilic salts of s-adenosyl-l-methionine (sam) with acylated taurine derivatives
DE19515275A1 (de) * 1995-04-26 1996-10-31 Knoll Ag Neue Verwendung von (S)-Adenosyl-L-methionin(SAMe)
US6759395B2 (en) 2000-12-18 2004-07-06 Orchid Chemicals & Pharmaceuticals, Ltd. Soft-gelatin capsule comprising S-adenosylmethionine and a method for producing the same
US8063024B2 (en) * 2005-01-26 2011-11-22 University Of Manitoba Use of S-adenosylmethionine, vitamin E, and vitamin C for the treatment of oxidative liver injury and insulin resistance
US20090012036A1 (en) * 2005-05-24 2009-01-08 Hebert Rolland F Stable S-adenosyl-L-methionine
ITMI20060629A1 (it) 2006-03-31 2007-10-01 Daniele Giovannone Composizioni solide orali a base di s-adenosilmetionina e processo per il loro ottenimento
CA2677053C (fr) * 2007-01-31 2016-03-15 Methylation Sciences International Srl Formulations pharmaceutiques a liberation prolongee de s-adenosylmethionine
US20090088404A1 (en) * 2007-01-31 2009-04-02 Methylation Sciences International Srl Extended Release Pharmaceutical Formulations of S-Adenosylmethionine
US20090197824A1 (en) * 2008-01-31 2009-08-06 Methylation Sciences International Srl Extended Release Pharmaceutical Formulations of S-Adenosylmethionine
ITMI20071374A1 (it) * 2007-07-10 2009-01-11 Gnosis Spa Sali stabili di s-adenosilmetionina e processo per il loro ottenimento.
US20100004191A1 (en) * 2008-07-01 2010-01-07 Rolland F Hebert Compositions of S-adenosyl-L-methionine.
US8329208B2 (en) 2009-07-28 2012-12-11 Methylation Sciences International Srl Pharmacokinetics of S-adenosylmethionine formulations
US20110027342A1 (en) * 2009-07-28 2011-02-03 Msi Methylation Sciences, Inc. S-adenosylmethionine formulations with enhanced bioavailability
EP2696879A4 (fr) 2011-04-15 2014-11-26 Scimar Ltd Utilisation de s-adénosylméthionine, de vitamine e et de vitamine c dans la prévention et le traitement d'un dysfonctionnement cardiovasculaire
CN106074589A (zh) 2012-10-17 2016-11-09 甲基化物科学国际有限公司 包含s‑腺苷甲硫氨酸及没食子酸酯的组合物
EP2945959B1 (fr) 2013-01-16 2020-05-13 Hebert Sam-E LLC S-adenosyl-l-methionine sous forme de sels d'indole-3-propionate stables

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2946781A (en) * 1957-02-06 1960-07-26 Merck & Co Inc Process for the preparation of adenosyl homocysteine
US3642772A (en) * 1968-09-04 1972-02-15 Boehringer Mannheim Gmbh Process for preparing s-adenosyl homocysteine

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS51125717A (en) * 1974-07-12 1976-11-02 Bioresearch Sas Preparation of ssadenosylmethionine sulfonate

Also Published As

Publication number Publication date
YU36037B (en) 1981-11-13
ES417377A1 (es) 1976-02-16
DK131868B (da) 1975-09-15
SU646915A3 (ru) 1979-02-05
AU474015B2 (en) 1976-07-08
CS195254B2 (en) 1980-01-31
HU167266B (fr) 1975-09-27
AR195350A1 (es) 1973-09-28
ATA664173A (de) 1977-06-15
CH592112A5 (fr) 1977-10-14
DE2336401C3 (de) 1980-03-13
NL7310706A (fr) 1974-02-05
FI52466B (fr) 1977-05-31
NO137941C (no) 1978-05-31
IE37913L (en) 1974-02-02
DD107461A5 (fr) 1974-08-05
IE37913B1 (en) 1977-11-09
IL42764A (en) 1976-04-30
FR2194425B1 (fr) 1976-04-09
AU5868073A (en) 1975-01-30
CA1006872A (en) 1977-03-15
FI52466C (fi) 1977-09-12
SE400085B (sv) 1978-03-13
NO137941B (no) 1978-02-13
NL152864B (nl) 1977-04-15
ZA734876B (en) 1974-06-26
PL87381B1 (fr) 1976-06-30
DK131868C (da) 1976-03-08
HK31580A (en) 1980-06-20
YU203073A (en) 1981-04-30
RO63451A (fr) 1978-07-15
AT341684B (de) 1978-02-27
DE2336401A1 (de) 1974-02-14
US3893999A (en) 1975-07-08
JPS5235726B2 (fr) 1977-09-10
DE2336401B2 (de) 1979-07-12
MX4544E (es) 1982-06-08
IL42764A0 (en) 1974-01-14
GB1425384A (en) 1976-02-18
FR2194425A1 (fr) 1974-03-01
JPS4992215A (fr) 1974-09-03

Similar Documents

Publication Publication Date Title
BE802981A (fr) Sel enzymatique, son procede de preparation et compositions therapeutiques le renfermant
RO67150A (fr) Procede pour la preparation des benzimidazole-2-carbamates substitues
BE799542A (fr) Cholesterol-oxydase et son procede de preparation,
CH555342A (de) Procede de preparation de derives de propanolamine.
BE804145A (fr) Guanidines, leur procede de preparation et leur application
BE765287A (fr) Procede de preparation de derives de 3-
BE808733A (fr) Procede de preparation de cyclohexane-diones-1,3
BE804942A (fr) Procede de preparation de cyclohexane-diones (1,3)
BE804341A (fr) Procede de preparation de cephemimycine
BE796813A (fr) Procede de preparation de perfluoroalkylesters
BE775499A (fr) Procede de preparation de copolymeres styrene-acrylonitrile
BE799742A (fr) Esters sulfonato-benzylmaloniques et procede de preparation,
BE803046A (fr) Procede de preparation de microcapsules
BE801697A (fr) Procede de preparation des benzyl-monocetals
BE763011A (fr) Procede de preparation de poly-organo-siloxanes
BE767990A (fr) Procede de preparation de monochlorobenzaldehydes
BE794066A (fr) Procede de preparation de 2-mercapto-benzimidazol
BE795636A (fr) Nitroimidazolylpyrimidines, et leur procede de preparation
BE744417A (fr) Procede de preparation des dihydroxyalcoylbenzenes
BE768303A (fr) Procede de preparation de 1,1,2,2-tetrahydroperfluoro- alcanols
BE761797A (fr) Procede de preparation de vinyl-trichlorosilane
BE798180A (fr) Procede de preparation d'anthracenes
BE805298A (fr) Procede de preparation de mono-malonates
BE795942A (fr) Procede de preparation des 2-hydroxy-4-alcoxy-benzophenones
BE805873A (fr) Procede de preparation de 9-cis-tricosene

Legal Events

Date Code Title Description
CA Change of address of the owner of the patent
RE20 Patent expired

Owner name: KNOLL A.G.

Effective date: 19930730